Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.16B |
| 2 |
Bank of America
BAC
|
+$855M |
| 3 |
Comcast
CMCSA
|
+$620M |
| 4 |
Amazon
AMZN
|
+$505M |
| 5 |
Micron Technology
MU
|
+$486M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$441M |
| 2 |
Palo Alto Networks
PANW
|
+$300M |
| 3 |
Verizon
VZ
|
+$286M |
| 4 |
Fidelity National Information Services
FIS
|
+$285M |
| 5 |
Stanley Black & Decker
SWK
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.22% |
| 2 | Financials | 6.16% |
| 3 | Industrials | 5.09% |
| 4 | Consumer Discretionary | 4.89% |
| 5 | Healthcare | 4.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PFPT
4201
CALL
DELISTED
Proofpoint, Inc.
PFPT
| $1.23M | ﹤0.01% |
13,800
+2,700
| +24% | +$245K |
|
4202
City Holding Co
CHCO
$2.07B
| $1.23M | ﹤0.01% |
+18,146
| New | +$1.27M |
|
|
DQ
4203
PUT
Daqo New Energy
DQ
$991M
| $1.22M | ﹤0.01% |
+103,000
| New | +$880K |
|
|
WW
4204
DELISTED
WW International
WW
| $1.22M | ﹤0.01% |
27,635
-9,176
| -25% | -$418K |
|
4205
CALL
iShares US Telecommunications ETF
IYZ
$1.23B
| $1.22M | ﹤0.01% |
41,600
+25,100
| +152% | +$744K |
|
4206
Ameris Bancorp
ABCB
$6.02B
| $1.22M | ﹤0.01% |
+25,360
| New | +$1.23M |
|
4207
AGCO
AGCO
$7.1B
| $1.22M | ﹤0.01% |
17,098
-1,116,728
| -98% | -$79.7M |
|
|
EVHC
4208
PUT
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $1.22M | ﹤0.01% |
35,300
+16,100
| +84% | +$563K |
|
|
AVDL
4209
DELISTED
Avadel Pharmaceuticals
AVDL
| $1.22M | ﹤0.01% |
148,675
+53,606
| +56% | +$503K |
|
|
TPC
4210
Tutor Perini Cor
TPC
$5.09B
| $1.22M | ﹤0.01% |
+48,009
| New | +$1.28M |
|
|
STBZ
4211
DELISTED
State Bank Financial Corporation. Common Stock
STBZ
| $1.22M | ﹤0.01% |
40,754
-2,066
| -5% | -$60.8K |
|
|
NLSN
4212
DELISTED
Nielsen Holdings plc
NLSN
| $1.22M | ﹤0.01% |
33,429
+27,831
| +497% | +$1.06M |
|
4213
CALL
Designer Brands
DBI
$299M
| $1.22M | ﹤0.01% |
56,800
-11,400
| -17% | -$234K |
|
|
LFC
4214
PUT
DELISTED
China Life Insurance Company Ltd.
LFC
| $1.22M | ﹤0.01% |
77,900
+66,800
| +602% | +$1.09M |
|
|
PVG
4215
PUT
DELISTED
PRETIUM RESOURCES INC.
PVG
| $1.22M | ﹤0.01% |
106,600
+46,600
| +78% | +$507K |
|
4216
ProShares UltraShort Euro
EUO
$33.1M
| $1.22M | ﹤0.01% |
57,331
-2,406
| -4% | -$52.7K |
|
4217
ProShares UltraPro Russell2000
URTY
$368M
| $1.21M | ﹤0.01% |
+14,742
| New | +$1.16M |
|
4218
Vanguard Dividend Appreciation ETF
VIG
$114B
| $1.21M | ﹤0.01% |
11,889
-30,400
| -72% | -$2.99M |
|
|
NSM
4219
CALL
DELISTED
Nationstar Mortgage Holdings
NSM
| $1.21M | ﹤0.01% |
65,500
+45,200
| +223% | +$826K |
|
4220
PUT
PTC Therapeutics
PTCT
$5.98B
| $1.21M | ﹤0.01% |
72,600
-36,100
| -33% | -$611K |
|
|
PVG
4221
DELISTED
PRETIUM RESOURCES INC.
PVG
| $1.21M | ﹤0.01% |
+106,170
| New | +$1.16M |
|
|
PRAH
4222
CALL
DELISTED
PRA Health Sciences, Inc.
PRAH
| $1.21M | ﹤0.01% |
13,300
+4,000
| +43% | +$333K |
|
4223
Calumet Specialty Products
CLMT
$4.19B
| $1.21M | ﹤0.01% |
157,135
+67,309
| +75% | +$561K |
|
4224
PUT
Murphy Oil
MUR
$4.96B
| $1.21M | ﹤0.01% |
38,900
+21,500
| +124% | +$599K |
|
4225
CALL
Sanofi
SNY
$105B
| $1.21M | ﹤0.01% |
28,100
-18,300
| -39% | -$844K |
|
Similar funds
Ken Griffin's Q4 2017 Portfolio in Review
As of Q4 2017, Ken Griffin held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Ken Griffin deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.
By sector, the portfolio is most concentrated in Technology at 6.2% of assets, down from 7.2% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.
- Ken Griffin's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
- Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
- Ken Griffin fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
- Ken Griffin's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
- Ken Griffin opened 1,440 new positions and closed 988 in Q4 2017.
- Ken Griffin's portfolio value rose 26% quarter-over-quarter to $164B.
Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.